Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Parasympathomimetics MeSH Descriptor Data 2025


MeSH Heading
Parasympathomimetics
Tree Number(s)
D27.505.696.663.050.675
Unique ID
D010277
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D010277
Annotation
note entry term PARASYMPATHOMIMETIC EFFECT: use only for the parasympathomimetic effect of a chemical substance
Scope Note
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
Entry Term(s)
Parasympathomimetic Agents
Parasympathomimetic Drugs
Parasympathomimetic Effect
Parasympathomimetic Effects
Registry Numbers
0
NLM Classification #
QV 122
See Also
Cholinesterase Inhibitors
Muscarinic Agonists
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2011/06/24
Parasympathomimetics Preferred
Parasympathomimetic Effect Related
page delivered in 0.146s